The current state of knowledge between LINC01133 and PC indicates three main established pathways, namely: (i) increased tumor proliferation mediated by C/EBPB; (ii) tumor progression stimulated by DKK1; and (iii) tumor progression mediated by miR-199b-5p/YY1, as shown in Figure 9. Here, CEBPB is linked to neoplasm.